Back to list

Breaking the bottleneck: AI microbial models kick off a new era of 'chip'-style biomanufacturing

Published on July 1, 2026

Breaking the bottleneck: AI microbial models kick off a new era of 'chip'-style biomanufacturing

Breaking the Bottleneck: AI-Driven Strain Foundation Models Usher in the "Chip" Era of Biomanufacturing

Industrial microbial strains act as the invisible "chips" of the biomanufacturing sector. At present, a large share of core industrial strain technologies are monopolized by overseas enterprises, leaving domestic manufacturers vulnerable to technological blockades. To break foreign patent barriers and develop self-owned industrial strains with independent intellectual property rights, the core bottleneck lies in the efficient and intelligent design of microbial strains. Microbial genes span an enormous sequence space, while intracellular metabolic regulatory networks are extremely intricate. Conventional R&D workflows relying on manual trial and error can no longer satisfy industrial demands—developing a mature industrial strain typically takes several years.

The adoption of artificial intelligence technology is fundamentally reshaping the landscape of strain research and development.


I. Traditional Strain Engineering: Trapped in the Mire of Empirical Trial and Error

 

The Sea of Lab Samples

The Sea of Lab Samples

To meet industrial fermentation standards, industrial strains require systematic engineering at both the genetic and metabolic pathway levels. Over the past decades, strain engineering has mainly followed two technical routes.

Mutagenesis screening is the most conventional R&D method: researchers induce random gene mutations via physical or chemical mutagenesis, then screen mutant libraries at large scale to isolate variants with improved performance. This technique fully depends on stochastic mutation. A full round of mutagenesis screening generally takes more than six months, with an extremely low positive mutation rate—comparable to looking for a needle in the dark. Though the combination of ARTP mutagenesis and high-throughput screening has boosted screening throughput by multiple orders of magnitude in recent years, the random nature of mutagenesis fundamentally prevents genuine rational directed design.

Rational metabolic engineering delivers more targeted modifications: researchers knock out or overexpress specific functional genes selectively based on existing metabolic network knowledge. Nevertheless, microbial regulatory networks feature tight coupling. As metabolic control analysis has long proven, metabolic flux is usually constrained by multiple rate-limiting steps. Single genetic modifications rarely resolve systemic flux bottlenecks, which is exactly where AI-powered tools can provide holistic solutions. A common issue emerges where targeted gene edits are theoretically sound, yet the engineered strain fails to deliver expected performance.

Conventional R&D relies heavily on individual researchers’ experience. From lab-scale shake-flask tests to industrial fermentation scale-up, uncertainties permeate the entire workflow. This not only extends R&D cycles but also raises major hurdles for domestic companies seeking to bypass foreign strain patents. Such inherent drawbacks of traditional methodologies create a strong imperative to integrate AI foundation models into strain design pipelines.


II. AI Steps onto the Stage: Foundation Models Decipher Microbial Genetic Code

 

Light & Gene Helix.

Light & Gene Helix

The efficiency limitations of traditional approaches directly drive the adoption of AI. The core strength of AI-powered strain foundation models rests on three key capabilities: training on massive biological datasets, building predictive correlations between gene sequences and strain phenotypes, and enabling a paradigm shift from blind trial and error to targeted intelligent design.

Several research institutions have developed specialized large language model expert systems tailored for strain engineering. These systems integrate tens of thousands of paper abstracts and open-access full texts, and leverage retrieval-augmented generation (RAG) to drastically improve accuracy when answering biology-specific research questions. The transformative value of this solution lies in deploying the knowledge integration strengths of large language models for strain development: researchers can input R&D inquiries (e.g., how to raise target product titer for a specific strain), and the model draws on its comprehensive literature database to output complete genetic engineering strategies.

At the genomic foundation model layer, open-source genome foundation models convert microbial DNA sequences, whole genomes and metagenomic samples into standardized numerical embeddings, laying a unified mathematical framework for systematic strain design. Complementary genome agents incorporate strain fitness boundary prediction into a unified genome-to-physiology modeling task, supporting precise forecasting of key industrial fermentation indicators including temperature tolerance, pH tolerance and salinity tolerance.

For downstream experimental optimization, AI agent frameworks built by research teams combine knowledge graphs, metabolic network models and automated experimental design algorithms. They mimic the collaborative workflow of professional R&D teams to automate core experimental design tasks such as culture medium formulation optimization.


III. From Digital Design to Industrial Deployment: Practical AI Applications at Matwings Technology

 

Three-Tier AI Strain Development Workflow

Three-Tier AI Strain Development Workflow

Matwings Technology has built a proprietary protein design foundation model trained on tens of billions of protein sequence data points and has completed more than 30 industrial-scale projects. This model differs drastically from conventional sequence homology-based tools: instead of filtering natural protein databases for homologous sequences, it directly generates novel functional protein sequences solely according to customized industrial performance requirements.

Complete strain engineering covers multiple phases. While protein design does not equal full strain development, it addresses the most critical pain point: customized construction of enzymatic components. The production capacity of industrial strains is heavily determined by the catalytic activity, thermal stability, and substrate specificity of intracellular enzymes.

The joint project between Matwings Technology and Jinsai Pharmaceutical serves as a typical case study. Using the general-purpose protein design foundation model, the research team quadrupled the alkali tolerance of a naturally alkali-sensitive single-domain antibody. This optimized variant has been successfully deployed on a 5,000-liter industrial fermentation line, and improved enzymatic performance directly lifts fermentation product yields.


IV. Three-Tier Architecture of AI-Driven Strain Foundation Models

Beyond standalone corporate breakthroughs, national-level initiatives are constructing a full-chain biological data service infrastructure covering biological resource preservation, bio-component prediction and generation, industrial enzyme design and full-strain engineering. These efforts steer the biomanufacturing industry from experiment-driven R&D toward data-intelligent development. A range of high-quality datasets suitable for AI training have been developed domestically, covering industrial strain genomes, functional promoters, regulatory elements, and various industrial enzymes, forming solid data support for AI strain foundation models.

Synthesizing existing technical progress, AI-powered strain foundation models have formed a multi-layer, progressive capability framework as follows:

Base Layer: Data Layer - Digital Decoding of Microbial Genes
This layer aggregates multi-source heterogeneous biological data (strain libraries, whole-genome sequences, metabolic pathways, academic literature, patents, etc.) into a standardized, unified data resource pool. Genomic foundation models complete computational feature extraction for DNA sequences, while genome agents connect genomic prediction with industrial tolerance parameter forecasting, building the data infrastructure that allows AI to interpret microbial genetic information.

Middle Layer: Design Layer - Computational Directed Strain Engineering
This layer applies biological large language models to build strain engineering expert systems that consolidate literature knowledge and generate tailored engineering strategies. AI agent frameworks link metabolic models with knowledge graphs to automate experimental design workflows such as medium formulation and fermentation condition optimization. Matwings Technology’s protein design foundation model focuses on core enzymatic modules to generate novel protein sequences on demand. This tier marks the shift of strain R&D from experience-led human operation to AI computational guidance.

Top Layer: Validation Layer - Closed-Loop Design-Test Iteration
A prominent pain point of traditional R&D is the disconnect between genetic design and experimental verification. AI-enabled dry-wet closed loops of computation and automated experimentation resolve this gap: after AI completes digital design of strains and protein components, the system seamlessly connects to automated experimental platforms for physical testing, and experimental data is fed back to iterate and refine the models. Domestic research institutes have established full-chain design-build-test-learn (DBTL) closed-loop technical systems, greatly accelerating strain iteration cycles. Such closed-loop iteration shortens the multi-year development timeline of traditional strain engineering to several months.


V. From Lab Technology to Large-Scale Industrialization

 

From Microbial Strains to Industrial Applications

From Microbial Strains to Industrial Applications

The industrial rollout of AI-driven strain foundation models is still in the early stage, yet its technical evolution path is clear. Large language model-assisted strain design has been practically validated; AI agents can independently execute full experimental planning workflows; and Matwings Technology’s delivery of dozens of industrial projects proves that AI-designed protein modules are readily applicable to mass manufacturing.

The next phase of industrial advancement relies on continuous data loop iteration. High-quality strain fermentation data carries greater value than algorithm frameworks themselves. Only by feeding real fermentation data generated from AI-designed strains back into model training can the precision and reliability of strain design be continuously upgraded.

When AI enables programmable, precise customization of industrial strains comparable to semiconductor chip design, the biomanufacturing industry will undergo transformative change. Strain development pipelines that once took years may in the future be finished within weeks, covering the full process from digital design to industrial-scale verification. Microbial strains, once shaped solely by natural evolution, will evolve into standardized, editable, and regulatable industrial biological components.